Skip to main content
$0.125 (0%)

High

$0.13

Low

$0.12

Trades

20

Turnover

$48,049

Volume

400,697
30 June 2023 at 3:57pm
Register to track CYP and receive email alerts.

Short Interest

ASIC data, 13 May 2026

% Shorted

0.00%
vs 0.00% prior report

Most Shorted Rank

661st
of 697 shorted ASX stocks

Peak Short

0.63%
Nov 2024

Days to Cover

0.0
at 50d avg vol
Subject
CYP Ann: Notification regarding unquoted securities - CYP

CYP Ann: Proposed issue of securities - CYP

CYP Ann: Cynata announces CEO succession and Board changes

CYP Ann: Change in substantial holding

CYP Ann: Appendix 3Ys x 6

CYP Ann: Top 20 Listed Optionholders & Distribution Schedule

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Cleansing Notice

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Results of Meeting

CYP Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Cynata Completes Oversubscribed Share Purchase Plan

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Proposed issue of securities - CYP

CYP Ann: Letter to Shareholders, Notice of Meeting & Proxy Form

CYP Ann: Cleansing Notice

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Target Market Determination

CYP Ann: Share Purchase Plan Booklet & Option Prospectus

CYP Ann: Cleansing Notice

CYP Ann: Application for quotation of securities - CYP

CYP Ann: Ethics Committee Approval for Proposed aGvHD Phase 2 Trial

CYP Ann: Capital Raising Presentation

CYP Ann: Proposed issue of securities - CYP

CYP Ann: Cynata completes $5.0m Placement and launches SPP

CYP Ann: Trading Halt

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: Cynata Adds New Sites for DFU Clinical Trial

CYP Ann: Appendix 4D & Half-Year Financial Statements

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Receives IRB Approval for aGvHD Clinical Trial

CYP Ann: Notice of Acceptance for Cynata Australian Patent

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: Cynata Receives $1.65m R&D Tax Incentive Refund

CYP Ann: Appendix 3Y - Janine Rolfe

CYP Ann: Notification regarding unquoted securities - CYP

CYP Ann: Results of AGM

CYP Ann: AGM Presentations

CYP Ann: Conference Data Demonstrating Consistency of Cynata MSCs

CYP Ann: Notice of Allowance for Cynata US Patent

CYP Ann: Notification of cessation of securities - CYP

CYP Ann: New Kidney Transplantation Clinical Trial for Cynata & LUMC

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Annual Report to Shareholders

CYP Ann: Letter to Shareholders, Notice of AGM & Proxy Form

CYP Ann: Notice of Allowance for Australia & Canada Cymerus Patents

CYP Ann: Successful Completion of Planned DSMB Review of DFU Trial

CYP Ann: Date of AGM and Closing Date for Director Nominations

Register to track CYP and receive email alerts.

Similar Companies

CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX